Iteris (NASDAQ:ITI) Stock, Quote.Headers.trade-ideas

Iteris

Iteris, Inc.

Iteris Inc is a provider of smart mobility infrastructure management solutions. Its solutions include traveler information systems, transportation performance measurement software, traffic analytics software, transportation operations software, transportation-related data sets, advanced sensing devices, managed services, traffic engineering services, and mobility consulting services. The company's cloud-enabled end-to-end solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient,and sustainable for everyone. The software solutions include ClearGuide, ClearRoute, Commercial Vehicle Operations, BlueArgus, TrafficCarma,and others.

American-Express-Platinum-credit-card

News

Downgrades

Markets

Analyst Ratings

AADI

This American Express Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Market,Sentiment,,Fear,And,Greed,Index,,Emotional,On,Stock,Market

Earnings

Pre-Market Outlook

Trading Ideas

BEKE

DOCS

MNDY

Dow Settles Higher But Records Weekly Loss: Greed Index Remains In &#39;Extreme Fear&#39; Zone

oil ai

Equities

Eurozone

Commodities

ANTX

BLND

MMAT

Crude Oil Rises; Blend Labs Shares Jump Following Q2 Results

Iteris Inc

Investors Title Co

In a new SEC filing on September 10, it was revealed that Shiba, SVP and CFO at Iteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>), executed a significant exercise of company stock options.
What Happened: A notable Form 4 filing on Tuesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000350868/000162828024040018//Archives/edgar/data/350868/000162828024040018/0001628280-24-040018-index.htm">U.S. Securities and Exchange Commission</a> revealed that Shiba, SVP and CFO at Iteris, exercised stock options for 12,080 shares of ITI, resulting in a transaction value of $31,710.
The Wednesday morning market activity shows Iteris shares down by 0.07%, trading at $7.09. This implies a total value of $31,710 for Shiba's 12,080 shares.
<h3>Unveiling the Story Behind Iteris</h3>
Iteris Inc is a provider of smart mobility infrastructure management solutions. Its solutions include traveler information systems, transportation performance measurement software, traffic analytics software, transportation operations software, transportation-related data sets, advanced sensing devices, managed services, traffic engineering services, and mobility consulting services. The company's cloud-enabled end-to-end solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient,and sustainable for everyone. The software solutions include ClearGuide, ClearRoute, Commercial Vehicle Operations, BlueArgus, TrafficCarma,and others.
<h3>Financial Insights: Iteris</h3>
Revenue Growth: Iteris's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 5.13%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 37.88%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Iteris's EPS is below the industry average. The company faced challenges with a current EPS of 0.01. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: Iteris's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.08.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 236.67 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 1.79 is lower than the industry average, implying a discounted valuation for Iteris's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 56.02, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>A Deep Dive into Insider Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000350868">Check Out The Full List Of Iteris's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Decision Unfolding At Iteris: Kerry A Shiba Exercises Options

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5b3249a8d1c31b00019b9fb4/gabe-hajde">Wells Fargo analyst Gabe Hajde</a> downgraded the rating for Sonoco Products Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SON#NYSE">SON</a>) from Equal-Weight to Underweight and lowered the price target from $54 to $52. Sonoco shares fell 0.5% to close at $50.57 on Tuesday. <a href="https://www.benzinga.com/quote/SON/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B. Riley Securities analyst Jeff Van Sinderen downgraded Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) from Buy to Neutral and slashed the price target from $8 to $7.2. Iteris shares gained 0.4% to close at $7.06 on Tuesday. S<a href="https://www.benzinga.com/quote/ITI/analyst-ratings">ee how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5910a1d1290fa70001bee784/kenneth-bruce">B of A Securities analyst Kenneth Bruce</a> downgraded American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) from Buy to Neutral and maintained the price target of $263. American Express shares fell 0.4% to close at $253.08 on Tuesday. <a href="https://www.benzinga.com/quote/AXP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities analyst Michael Ciarmoli downgraded the rating for Triumph Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGI#NYSE">TGI</a>) from Buy to Hold, while cutting the price target from $17 to $15. Triumph shares fell 1.9% to settle at $13.41 on Tuesday. <a href="https://www.benzinga.com/quote/TGI/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58ac8cd8b85e930001f970ac/boris-peaker">TD Cowen analyst Boris Peaker </a>downgraded the rating for Aadi Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AADI#NASDAQ">AADI</a>) from Buy to Hold. Aadi Bioscience shares gained 3.9% to close at $1.62 on Tuesday. <a href="https://www.benzinga.com/quote/AADI/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40482031/top-3-materials-stocks-which-could-blast-off-this-month">Top 3 Materials Stocks Which Could Blast Off This Month</a></li>
</ul>
Considering buying AXP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21090928/image-183-1024x502.png" alt="" class="wp-image-506239" style="width:596px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21090928/image-183-1024x502.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21090928/image-183-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21090928/image-183-768x377.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/21090928/image-183.png 1338w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

B. Riley Securities analyst Jeff Van Sinderen downgrades Iteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) from Buy to Neutral and lowers the price target from $8 to $7.2.

Price Target

B. Riley Securities Downgrades Iteris to Neutral, Lowers Price Target to $7.2

It was reported on August 13, that Samjo Management LLC, 10% Owner at Iteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) executed a significant insider sell, according to an SEC filing.
What Happened: LLC opted to sell 2,048,300 shares of Iteris, according to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000350868/000091957424004381//Archives/edgar/data/350868/000091957424004381/0000919574-24-004381-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The transaction's total worth stands at $14,323,617.
The latest market snapshot at Tuesday morning reveals Iteris shares down by 0.0%, trading at $6.98.
<h3>Discovering Iteris: A Closer Look</h3>
Iteris Inc is a provider of smart mobility infrastructure management solutions. Its solutions include traveler information systems, transportation performance measurement software, traffic analytics software, transportation operations software, transportation-related data sets, advanced sensing devices, managed services, traffic engineering services, and mobility consulting services. The company's cloud-enabled end-to-end solutions help public transportation agencies, municipalities, commercial entities and other transportation infrastructure providers monitor, visualize, and optimize mobility infrastructure to make mobility safe, efficient,and sustainable for everyone. The software solutions include ClearGuide, ClearRoute, Commercial Vehicle Operations, BlueArgus, TrafficCarma,and others.
<h3>Iteris's Economic Impact: An Analysis</h3>
Revenue Growth: Iteris's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 5.13%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 37.88%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Iteris's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.01.
</li>
</ul>
Debt Management: Iteris's debt-to-equity ratio is below the industry average. With a ratio of 0.08, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 232.67 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 1.76 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 55.22 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000350868">Check Out The Full List Of Iteris's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

10% Owner Of Iteris Makes $14.32M Sale

Maxim Group analyst Allen Klee downgrades Iteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) from Buy to Hold.

Maxim Group Downgrades Iteris to Hold

The CNN Money Fear and Greed index remained in the &#8220;Extreme Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday, after recording sharp losses earlier during the week. However, major indices recorded losses last week, with the Dow and Nasdaq falling by 0.6% and 0.18%, respectively.
On Monday, the Dow dipped 1,000 points, while the S&amp;P 500 dipped around 3% to record its worst day since 2022.
On the economic data front, the total number of active U.S. oil rigs increased by three to 485 rigs this week, Baker Hughes Inc. reported.
Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) shares jumped 38.7% on Friday after the company reported better-than-expected first-quarter financial results. Additionally, the company issued FY24 revenue guidance above estimates. Shares of Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) surged 63.6% after the company announced it would be acquired by Almaviva for $335 million.
Most sectors on the S&amp;P 500 closed on a positive note, with communication services, real estate, and information technology stocks recording the biggest gains on Friday. However, materials stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 51 points to 39,497.54 on Friday. The S&amp;P 500 rose 0.47% at 5,344.16, while the Nasdaq Composite jumped 0.51% at 16,745.30 during Friday's session.
Investors are awaiting earnings results from Monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>), Sun Life Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLF#NYSE">SLF</a>), and KE Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NASDAQ">BEKE</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 23.9, the index remained in the &#8220;Extreme Fear&#8221; zone on Friday, versus a prior reading of 24.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/08/40298443/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-y">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

Dow Settles Higher But Records Weekly Loss: Greed Index Remains In 'Extreme Fear' Zone

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Friday.
The Dow traded down 0.05% to 39,426.08 while the NASDAQ rose 0.36% to 16,720.23. The S&amp;P 500 also rose, gaining, 0.30% to 5,335.46.
Leading and Lagging Sectors Information technology shares climbed by 0.6% on Friday.
In trading on Friday, industrials shares fell 0.3%.
Top Headline
The total number of active U.S. oil rigs increased by three to 485 rigs this week, Baker Hughes Inc reported.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) shares shot up 36% to $35.02 after the company reported better-than-expected first-quarter financial results. Additionally, the company issued FY24 revenue guidance above estimates.</li>
<li>Shares of Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) got a boost, surging 63% to $6.99 after the company announced it will be acquired by Almaviva for $335 million.</li>
<li>Blend Labs, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares were also up, gaining 19% to $3.2050 after the company reported better-than-expected second-quarter financial results. Also, William Blair upgraded the stock from Market Perform to Outperform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AN2 Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTX#NASDAQ">ANTX</a>) shares dropped 60% to $1.0650 after the company announced that it will discontinue its EBO-301 study following topline results from its Phase 2 part of the study in treatment-refractory patients with MAC lung disease.</li>
<li>Shares of Vicinity Motor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEV#NASDAQ">VEV</a>) were down 64% to $0.1091. Vicinity Motor will release financial results for the second quarter, after the closing bell on Wednesday, Aug. 14.</li>
<li>Meta Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMAT#NASDAQ">MMAT</a>) was down, falling 44% to $1.16 after the company disclosed in an SEC filing that it ceased operations and filed a voluntary petition for relief under the provisions of Chapter 7 of Title 11 in the US Bankruptcy Court.</li>
</ul>
Commodities In commodity news, oil traded up 0.9% to $76.85 while gold traded up 0.2% at $2,467.20.
Silver traded down 0.3% to $27.515 on Friday, while copper rose 0.7% to $3.9865.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 rose 0.57%, Germany's DAX rose 0.24% and France's CAC 40 rose 0.31%. Spain's IBEX 35 Index rose 0.76%, while London's FTSE 100 rose 0.28%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.56%, Hong Kong's Hang Seng Index gaining 1.17%, China's Shanghai Composite Index falling 0.27% and S&amp;P BSE Sensex gaining 1.04%.
Economics
The total number of active U.S. oil rigs increased by three to 485 rigs this week, Baker Hughes Inc reported.
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40253347/top-3-utilities-stocks-that-could-lead-to-your-biggest-gains-this-month">Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month </a></li>
</ul>

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 0.1% on Friday.
The Dow traded down 0.12% to 39,399.04 while the NASDAQ fell 0.20% to 16,626.36. The S&amp;P 500 also fell, dropping, 0.02% to 5,318.02.
Leading and Lagging Sectors Health care shares climbed by 0.3% on Friday.
In trading on Friday, communication services shares fell 0.6%.
Top Headline 
Shares of EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) dipped around 16% on Friday after the company reported worse-than-expected second-quarter financial results..
The company reported a second-quarter loss per share of 76 cents, which missed the street view of 17 cents loss. Quarterly revenues of $3.953 billion missed the analyst consensus of $3.983 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>FSD Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUGE#NASDAQ">HUGE</a>) shares shot up 227% to $0.2995.</li>
<li>Shares of Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) got a boost, surging 63% to $6.98 after the company announced it will be acquired by Almaviva for $335 million.</li>
<li>Hyzon Motors Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYZN#NASDAQ">HYZN</a>) shares were also up, gaining 36% to $0.1167. Hyzon will host a conference call to discuss its second quarter earnings results on Tuesday, Aug. 13.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AN2 Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTX#NASDAQ">ANTX</a>) shares dropped 60% to $1.05 after the company announced that it will discontinue its EBO-301 study following topline results from its Phase 2 part of the study in treatment-refractory patients with MAC lung disease.</li>
<li>Shares of Vicinity Motor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEV#NASDAQ">VEV</a>) were down 56% to $0.1335. Vicinity Motor will release financial results for the second quarter, after the closing bell on Wednesday, Aug. 14.</li>
<li>Meta Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMAT#NASDAQ">MMAT</a>) was down, falling 50% to $1.0340 after the company disclosed in an SEC filing that it ceased operations and filed a voluntary petition for relief under the provisions of Chapter 7 of Title 11 in the US Bankruptcy Court.</li>
</ul>
Commodities In commodity news, oil traded up 0.6% to $76.61 while gold traded up 0.3% at $2,470.40.
Silver traded down 0.5% to $27.48 on Friday, while copper rose 0.9% to $3.9930.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.57%, Germany's DAX rose 0.24% and France's CAC 40 rose 0.31%. Spain's IBEX 35 Index rose 0.76%, while London's FTSE 100 rose 0.28%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.56%, Hong Kong's Hang Seng Index gaining 1.17%, China's Shanghai Composite Index falling 0.27% and S&amp;P BSE Sensex gaining 1.04%.
Economics
The Baker Hughes rig count report for the latest week will be released today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40253347/top-3-utilities-stocks-that-could-lead-to-your-biggest-gains-this-month">Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month</a></li>
</ul>

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

HYZN

SATS

US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results

WIIM

Iteris shares are trading higher after the company announce dit will be acquired by Almaviva for $335 million.

Iteris, Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) stock surged Friday morning after private Italian digital innovation group Almaviva S.p.A. agreed to acquire the company in a <a href="https://www.benzinga.com/pressreleases/24/08/b40276076/iteris-to-be-acquired-by-almaviva-for-335-million" target="_blank" rel="noreferrer noopener">$335 million all-cash deal</a>.
As per the terms, Iteris shareholders will receive $7.20 per share. The cash purchase price represents a 68% premium over Iteris&#8217;s closing share price on August 8, 2024.
The Iteris Board of Directors unanimously approved the transaction and will recommend it to shareholders.
The transaction, expected to close in 2024 pending Iteris shareholder approval, regulatory approvals, and other conditions, will be financed by Almaviva through committed debt.
Following completion, Iteris will become privately held, and its common stock will be delisted from Nasdaq.
Joe Bergera, President and CEO of Iteris, said, &#8220;Iteris has been a pioneer and leader in intelligent transportation systems for more than 15 years and the agreement we reached with Almaviva is a testament to the grit, determination and innovative spirit of our entire team.&#8221;
&#8220;Almaviva shares our vision for the future of digital mobility and our commitment to excellence. With this transaction, our team will be strongly positioned to continue to innovate and expand the global adoption of our ClearMobility Platform.&#8221;
Yesterday, the company reported&nbsp;first-quarter FY25 adjusted EPS&nbsp;of $0.06,&nbsp;beating the consensus of&nbsp;$0.05. Sales&nbsp;of $45.8 million <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40266163/iteris-reports-record-quarterly-revenue-of-45-8-million" rel="noreferrer noopener">exceeded the street view of&nbsp;$44.182 million</a>.
As of June-end, Iteris&#8217; cash and cash equivalents stood at $21.4 million.
The company reiterated revenue guidance of $188.0 million &#8211; $194.0 million (vs. estimate of $189.257 million) for FY25 and expects second-quarter revenues of $44.0 million &#8211; $48.0 <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">million (vs. $47.78 million estimate)</a>.
Price Action: ITI shares are up 62% at $6.94 premarket at the last check Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Guidance

Asset Sales

Small Cap

Movers

Why Is Electronic Equipment Company Iteris Stock Jumping Premarket Friday?

Shares of Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) rose sharply in today's pre-market trading reported better-than-expected first-quarter financial results and issued <a href="https://www.benzinga.com/news/earnings/24/08/40269788/doximity-stock-soars-on-q1-earnings-the-details">strong FY24 revenue guidance.</a>
Doximity's first-quarter revenue increased 17% year-over-year to $126.68 million, beating the consensus estimate of $119.92 million, according to Benzinga Pro. The company reported adjusted earnings of 28 cents per share, beating analyst estimates of 22 cents per share.
Doximity shares jumped 28.6% to $33.00 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) rose 61.7% to $6.92 in today's pre-market trading after the company agreed to be acquired by Almaviva for $335 million.</li>
<li>FSD Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUGE#NASDAQ">HUGE</a>) gained 53% to $0.14 in pre-market trading after gaining 16% on Thursday.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 45.8% to $2.80 in pre-market trading. Nauticus Robotics partnered with Florida Atlantic University for cost-effective Aquanaut Mark 2 testing.</li>
<li>Avinger, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares rose 28.3% to $1.54 in pre-market trading after reporting second-quarter results.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) gained 27.7% to $10.14 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued Q3 product revenue guidance above estimates.</li>
<li>Clearmind Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) shares gained 27.7% to $1.52 in pre-market trading after declining around 8% on Thursday.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) gained 27.1% to $2.30 in pre-market trading after the company announced AI-powered tool enhancements to its integrations with Reddit and X.</li>
<li>Babcock &amp; Wilcox Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) gained 22.5% to $1.36 following second-quarter results.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) jumped 22.3% to $32.11 in pre-market trading after the company reported better-than-expected second-quarter revenue results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) shares dipped 30.8% to $5.66 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>PubMatic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>) shares declined 26.4% to $14.40 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>Cutera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUTR#NASDAQ">CUTR</a>) shares declined 21.4% to $0.88 in pre-market trading after the company reported worse-than-expected second-quarter revenue results and cut its FY24 revenue guidance below estimates.</li>
<li>Nerdy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) declined 20.1% to $1.27 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>FiscalNote Holdings, Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) shares fell 18.3% to $1.12 in pre-market trading after reporting second-quarter results.</li>
<li>Eventbrite, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) fell 17.1% to $3.15 in today's pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued FY24 revenue guidance below estimates.</li>
<li>AMMO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) shares fell 16.7% to $1.35 in pre-market trading after the company reported weak first-quarter sales.</li>
<li>Five9, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) fell 16.4% to $35.49 in pre-market trading after the company posted second-quarter results.</li>
<li>Trevena, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) fell 14.7% to $0.19 pre-market trading after the company reported second-quarter results.</li>
<li>Anew Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WENA#NASDAQ">WENA</a>) shares fell 10.1% to $1.15 in pre-market trading after gaining 17% on Thursday.</li>
</ul>
Now Read This: &lt;a href=&#8221;https://www.benzinga.com/news/earnings/24/04/38307448/investor-sentiment-decreases-further-s-p-500-falls-for-fourth-straight-session&#8221;&gt;&lt;em&gt; Investor Sentiment Decreases Further, S&amp;P 500 Falls For Fourth Straight Session&lt;/em&gt;&lt;/a&gt;

AVGR

CMND

CUTR

FIVN

IOVA

KITT

MRIN

NOTE

NRDY

POWW

PUBM

TRVN

WENA

Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

Iteris Shareholders to Receive&nbsp;$7.20&nbsp;Per Share in Cash, Representing Significant Premium of&nbsp;68%
Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) (&quot;Iteris&quot; or the &quot;Company&quot;), the world&#39;s trusted technology ecosystem for smart mobility infrastructure management, today announced that it has entered into a definitive merger agreement to be acquired by Almaviva S.p.A. (&quot;Almaviva&quot;), a private Italian digital innovation group, in an all-cash transaction valuing Iteris at approximately&nbsp;$335 million&nbsp;equity value. Under the terms of the agreement, Iteris shareholders will receive&nbsp;$7.20&nbsp;in cash for each share of Iteris common stock.

Iteris To Be Acquired By Almaviva For $335M, Shareholders Set To Receive $7.20 Per Share

Iteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. The company reported quarterly sales of $45.777 million which beat the analyst consensus estimate of $44.182 million by 3.61 percent. This is a 5.13 percent increase over sales of $43.545 million the same period last year.

Earnings Beats

Iteris Q1 2025 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $45.777M Beat $44.182M Estimate

Iteris will provide managed services that support 511 traveler information operations region-wide
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iteris.com&amp;esheet=54097800&amp;newsitemid=20240723760174&amp;lan=en-US&amp;anchor=Iteris%2C+Inc&amp;index=1&amp;md5=a2f45e543f8af62fb993edfd427ee484">Iteris, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>), the world's trusted technology ecosystem for smart mobility infrastructure management, today announced the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmtc.ca.gov%2F&amp;esheet=54097800&amp;newsitemid=20240723760174&amp;lan=en-US&amp;anchor=Metropolitan+Transportation+Commission&amp;index=2&amp;md5=1ddf3981d6dd7df30161b442e309339f">Metropolitan Transportation Commission</a> (MTC) has awarded Iteris a $3.75 million contract for ongoing operational support in the San Francisco Bay Area.

Contracts

Iteris Receives $3.75M Contract From San Francisco Bay Area Metropolitan Transportation Commission

Iteris Awarded $2M IDIQ Contract by Texas Department of Transportation to Enhance Traffic Management and Safety in Houston District

With U.S. stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Enerpac Tool Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAC#NYSE">EPAC</a>) to report quarterly earnings at 47 cents per share on revenue of $153.20 million after the closing bell. Enerpac Tool Group shares gained 1.9% to $39.22 in after-hours trading.</li>
<li>Singular Genomics Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMIC#NASDAQ">OMIC</a>) reported a 1-for-30 reverse stock split. Singular Genomics shares fell 9.3% to $0.3180 in the after-hours trading session.</li>
<li>Analysts are expecting Beyond Air, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) to post a quarterly loss at $0.48 per share on revenue of $747.20 thousand. The company will release earnings after the markets close. Beyond Air shares gained 8.1% to $1.34 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) filed for a $150 million mixed securities shelf offering. Iteris shares fell 1.2% to $4.0201 in the after-hours trading session.</li>
<li>Stoke Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) said its Chief Operating Officer Huw Nash will step down, but will continue as Chief Business Officer, effective June 18. Stoke Therapeutics shares fell 3.6% to close at $14.23 on Friday.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39432128/2m-bet-on-exxon-mobil-check-out-these-3-stocks-insiders-are-buying">$2M Bet On Exxon Mobil? Check Out These 3 Stocks Insiders Are Buying</a>

EPAC

OMIC

STOK

XAIR

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

Offerings

Iteris Files For $150M Mixed Securities Shelf Offering

EF Hutton analyst Tim Moore maintains Iteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) with a Buy and maintains $7 price target.

EF Hutton Maintains Buy on Iteris, Maintains $7 Price Target

Adjusted EBITDA margin in the range of&nbsp;5.5%&nbsp;to&nbsp;6.5%, representing a 324 basis points decline year over year at the midpoint of the&nbsp;guidance&nbsp;range due to anticipated investments in research and development and sales to support recent and planned new product releases

Iteris Expects Q1 Total Revenues Of $43.5M - $45.5M (Est $46.401M); Represents Organic Growth Of 2% At Mid-point Of Guidance Range Due To Timing Of New Product Introduction Cycles

Adjusted EBITDA margin in the range of&nbsp;8.0%&nbsp;to&nbsp;10.0%&nbsp;of revenue, representing a 150 basis points improvement at the midpoint of the&nbsp;guidance&nbsp;range

Iteris Sees FY25 Total Revenues Of $188M - $194M, Est $190.310M

Iteris bags $2M contract from TxDOT to provide traffic solution systems

Iteris gets $3.75M contract from San Francisco Bay Area Metropolitan Transportation Commission

Iteris GAAP EPS of $0.01 misses by $0.01, revenue of $45.78M beats by $1.6M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Iteris (NASDAQ:<a href="https://investorplace.com/stock-quotes/iti-stock-quote/">ITI</a>) just reported results for the first quarter of 2025.<ul><li>Iteris reported earnings per share of 6 cents. This was above the analyst estimate for EPS of 5 cents.</li><li>The company reported revenue of $45.78 million.</li><li>This was 3.61% better than the analyst estimate for revenue of $44.18 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/iti-stock-earnings-iteris-for-q1-of-2025/">ITI Stock Earnings: Iteris Beats EPS, Beats Revenue for Q1 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ITI Stock Earnings: Iteris Beats EPS, Beats Revenue for Q1 2025

Iteris (ITI) has shared an announcement. Iteris, Inc., a leading provider of smart mobility infrastructure management solutions, has amended its CE...

Iteris Enhances Leadership Structure Amidst Strategic Merger

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Iteris&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/iti-stock-quote/">ITI</a>) stock is soaring higher on Friday after the intelligent transportation systems technology solutions company announced a <a href="https://www.nasdaq.com/press-release/iteris-be-acquired-almaviva-335-million-2024-08-09">new acquisition deal</a>.



This will see Iteris be acquired by the private digital innovation group Almaviva. It will use cash to purchase Iteris for $335 million.



That offer has Almaviva valuing shares of ITI stock at $7.20 each. This represents a roughly 68% premium to the stock&rsquo;s prior closing price.



Joe Bergera, president and CEO of&nbsp;Iteris, said the following about the deal.




&ldquo;Almaviva shares our vision for the future of digital mobility and our commitment to excellence. With this transaction, our team will be strongly positioned to continue to innovate and expand the global adoption of our ClearMobility Platform.&rdquo;




<h2>ITI Stock Acquisition Details</h2>



Iteris&rsquo; board of directors has given its unanimous support to the acquisition by Almaviva. Not the deal just needs approval from regulators and shareholders of ITI stock. If all of that is obtained, the two companies expect the deal to close sometime this year.



ITI stock is up 64% as of Friday morning. Investors will also note that the shares will go private once this deal closes.



There are more stock market stories traders are going to want to read about below!



We have all of the hottest stock market news that investors need to know about on Friday! That includes a breakdown of the biggest pre-market stock movers this morning and other recent news. All of this is ready to go at the links below!



<h2>More Friday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-9th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Friday</a></li>



<li><a href="https://investorplace.com/2024/08/why-this-weeks-jobless-claims-report-is-easing-recession-fears/">Why This Week&rsquo;s Jobless Claims Report Is Easing Recession Fears</a></li>



<li><a href="https://investorplace.com/2024/08/apps-stock-is-up-60-whats-going-on-with-digital-turbine-today/">APPS Stock Is Up 60%. What&rsquo;s Going On With Digital Turbine Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-iteris-iti-stock-up-64-today/">Why Is Iteris (ITI) Stock Up 64% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Iteris (ITI) Stock Up 64% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have all of the biggest pre-market stock movers that traders need to know about on Friday morning!



Moving stocks this morning and more earnings reports, an acquisition deal, liquidation news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Iteris (NASDAQ:<a href="https://investorplace.com/stock-quotes/iti-stock-quote/">ITI</a>) stock is rocketing more than 62% <a href="https://www.nasdaq.com/press-release/iteris-be-acquired-almaviva-335-million-2024-08-09">alongside an acquisition deal</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) shares are soaring over 61% on a <a href="https://www.nasdaq.com/press-release/nauticus-robotics-enters-aquanaut-mark-2-testing-partnership-fau-2024-08-08">new testing partnership</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) stock is surging more than 37% alongside heavy pre-market trading.</li>



<li>Bone Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bblg-stock-quote/">BBLG</a>) shares are gaining over 30% with the <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318504957&amp;type=PDF&amp;symbol=BBLG&amp;cdn=81b72413280ee9face7494c21cc37055&amp;companyName=Bone+Biologics+Corp&amp;formType=ARS&amp;formDescription=Annual+Report+to+Security+Holders&amp;dateFiled=2024-08-08">release of its annual report</a>.</li>



<li>Pitney Bowes (NYSE:<a href="https://investorplace.com/stock-quotes/pbi-stock-quote/">PBI</a>) stock is rising more than 30% on plans to <a href="https://finance.yahoo.com/news/pitney-bowes-liquidate-ecommerce-unit-221312483.html">liquidate its e-commerce unit</a>.</li>



<li>Marin Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrin-stock-quote/">MRIN</a>) shares are increasing over 28% after <a href="https://www.businesswire.com/news/home/20240808458407/en/Marin-Software-Extends-Reach-with-Reddit-and-X-Support">adding support for Reddit and X</a>, previously called Twitter.</li>



<li>Clearmind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>) stock is heading more than 27% higher without any clear news this morning.</li>



<li>Doximity (NYSE:<a href="https://investorplace.com/stock-quotes/docs-stock-quote/">DOCS</a>) shares are climbing over 27% on a <a href="https://www.marketwatch.com/story/doximity-shares-rally-after-beating-1q-earnings-guidance-expectations-b9ce97d7?mod=markets">fiscal Q1 earnings beat</a>.</li>



<li>Satellogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/satl-stock-quote/">SATL</a>) stock is jumping more than 26% today.</li>



<li>Babcock &amp; Wilcox (NYSE:<a href="https://investorplace.com/stock-quotes/bw-stock-quote/">BW</a>) shares are up over 25% after releasing its <a href="https://www.businesswire.com/news/home/20240808728017/en/Babcock-Wilcox-Enterprises-Reports-Second-Quarter-2024-Results-Earnings-Growth-Driven-By-Strong-Operating-Performance">Q2 earnings report</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>AN2 Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/antx-stock-quote/">ANTX</a>) stock is diving more than 33% <a href="https://www.nasdaq.com/press-release/an2-therapeutics-provides-update-ebo-301-phase-2-3-study-evaluating-epetraborole">with a clinical trial update</a>.</li>



<li>American Vanguard (NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) shares are tumbling over 29% with the <a href="https://www.nasdaq.com/press-release/american-vanguard-reports-q2-2024-results-2024-08-08">release of its latest earnings report</a>.</li>



<li>PubMatic (NASDAQ:<a href="https://investorplace.com/stock-quotes/pubm-stock-quote/">PUBM</a>) stock is taking a more than 27% beating on <a href="https://www.stocktitan.net/news/PUBM/pub-matic-announces-second-quarter-2024-financial-zmrbbq0dmfh8.html">missed Q2 revenue</a>.</li>



<li>Eventbrite (NYSE:<a href="https://investorplace.com/stock-quotes/eb-stock-quote/">EB</a>) shares are sliding over 23% alongside <a href="https://www.tipranks.com/news/company-announcements/eventbrite-announces-layoffs-and-welcomes-new-coo-cfo">layoffs and leadership changes</a>.</li>



<li>Beauty Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/skin-stock-quote/">SKIN</a>) stock is decreasing more than 22% after <a href="https://www.nasdaq.com/press-release/beautyhealth-reports-second-quarter-2024-financial-results-2024-08-08">posting its Q2 earnings report</a>.</li>



<li>Cutera (NASDAQ:<a href="https://investorplace.com/stock-quotes/cutr-stock-quote/">CUTR</a>) shares are dropping over 21% with its <a href="https://www.nasdaq.com/press-release/cuterar-announces-second-quarter-2024-financial-results-2024-08-08">latest earnings news</a>.</li>



<li>Microvast (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvst-stock-quote/">MVST</a>) stock is falling more than 19% after releasing its <a href="https://ir.microvast.com/static-files/b376f438-a4e5-4a1a-ac22-a6107e450b24">Q2 2024 earnings</a>.</li>



<li>FiscalNote (NYSE:<a href="https://investorplace.com/stock-quotes/note-stock-quote/">NOTE</a>) shares are slipping over 18% after <a href="https://finance.yahoo.com/news/fiscalnote-holdings-inc-note-reports-231505554.html">posting a Q2 loss</a>.</li>



<li>Nerdy (NYSE:<a href="https://investorplace.com/stock-quotes/nrdy-stock-quote/">NRDY</a>) stock is dipping more than 18% after <a href="https://www.nasdaq.com/press-release/nerdy-announces-second-quarter-2024-financial-results-2024-08-08">releasing its Q2 earnings report</a>.</li>



<li>Five9 (NASDAQ:<a href="https://investorplace.com/stock-quotes/fivn-stock-quote/">FIVN</a>) shares close out our pre-market stock movers down over 15% with its <a href="https://www.nasdaq.com/press-release/five9-surpasses-1-billion-annual-revenue-run-rate-2024-08-08">most recent earnings report</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Iteris, Inc. (ITI) Q1 2025 Earnings Call Transcript

Iteris Is Acquired At A Little Under Fair Value

Iteris (ITI – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Jeff Van Sinderen from B.Riley...

Hold Rating on Iteris Amid Acquisition by Almaviva at $7.20 Per Share

BBLG

MVST

SATL

SKIN

Screenshot 2024-08-06 at 10.00.06 PM

Emerging Markets

Movers & Shakers

Iteris And Sumitomo Electric Introduce Advanced Pedestrian Safety Solution To Reduce Fatalities In North America

Screenshot 2024-04-17 at 5.30.17 PM

From Providing Cutting-Edge AI Traffic Management Tech To Helping Manage It – Iteris Could Be Key Ally For Government Agencies Revolutionizing America&#39;s Roadways

Screenshot 2024-03-28 at 5.51.12 PM

Navigating the Future: Iteris&#39; Expertise In Intelligent Transportation Systems (ITS) Architecture And Design

Screenshot 2024-02-29 at 7.03.54 PM

How Iteris&#39; (NASDAQ: ITI) ClearGuide Analytics Are Revolutionizing Roadway Operations And Saving Lives Across America

Screenshot 2024-02-21 at 6.38.57 PM

The Future Of Transportation? How Iteris (NASDAQ: ITI) Has Been Driving Innovation And Helping Set Standards In The Connected And Automated Vehicle Space

Press Releases

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Iteris, Inc. - ITI

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, DFS on Behalf of Shareholders

ITI Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Iteris, Inc. is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, TTNP on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders

Kuehn Law Encourages EVBN, ITI, FRZA, and SDIG Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SDIG, ARC, ITI on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLIC, ITI, AG, HSPO on Behalf of Shareholders

Kuehn Law Encourages FRZA, AG, ITI, and FLIC Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLIC, ITI, AG, FRZA on Behalf of Shareholders

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Iteris

Iteris (ITI) Forecast

Iteris (NASDAQ:ITI) Stock, Quote.Headers.trade-ideas